Tumor Necrosis Factor Antagonists: Different Kinetics and/or Mechanisms of Action May Explain Differences in the Risk for Developing Granulomatous Infection-Reference-Cited by-同舟云学术

Tumor Necrosis Factor Antagonists: Different Kinetics and/or Mechanisms of Action May Explain Differences in the Risk for Developing Granulomatous Infection

Published:2006-12 Issue:3 Volume:36 Page:159-167
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Furst Daniel E.,Wallis Robert,Broder Michael,Beenhouwer David O.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference84 articles.

1. Methotrexate use in rheumatoid arthritis;Alarcon;Immunopharmacology,2000

2. New Two-Year Data Show That Most Rheumatoid Arthritis Patients Treated with ENBREL Plus Methotrexate Had No Progression of Joint Damage. http://www.amgen.com/media/media_pr_detail.jsp?year=2004&releaseID=631786. Accessed December 5, 2005.

3. 500,000 patients have now been treated with REMICADE® worldwide. News-Medical.Net (Pharmaceutical News), April 21, 2004. http://www.news-medical.net/?id=729. Accessed November 29, 2005.

4. Infliximab and methotrexate in the treatment of rheumatoid arthritis;Lipsky;N Engl J Med,2000

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparisons of infection events associated with tumor necrosis factor inhibitors in patients with inflammatory arthritis: A systematic review and network meta-analysis;Frontiers in Pharmacology;2024-07-11

2. Leprosy and Autoimmunity;Infection and Autoimmunity;2024

3. Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders;Frontiers in Immunology;2023-07-07

4. Tumor necrosis factor-α inhibitor-related autoimmune disorders;Autoimmunity Reviews;2023-07

5. Exploring the role of biologics in depression;Cellular Signalling;2022-10